EPA SBIR Phase I (2026 solicitation 68HERW26R0102)
EPA's annual SBIR Phase I solicitation (68HERW26R0102 for 2026) awards about 25 firm-fixed-price contracts of up to $100,000 for six-month proof-of-concept projects on EPA-set topics such as PFAS treatment and sensing, water reuse, food waste, battery mineral recovery and safer chemicals. Offered by Environmental Protection Agency; awards $100K; applications due November 8, 2026.
Key Facts
- Funder
- Environmental Protection Agency
- Award amount
- $100K
- Deadline
- November 8, 2026
- Geography
- United States
- Status
- Open
About This Grant
EPA's annual SBIR Phase I solicitation (68HERW26R0102 for 2026) awards about 25 firm-fixed-price contracts of up to $100,000 for six-month proof-of-concept projects on EPA-set topics such as PFAS treatment and sensing, water reuse, food waste, battery mineral recovery and safer chemicals. Proposals go through FedConnect by 11:59 p.m. ET on November 8, 2026; one proposal per company. Award: Up to $100,000 for 6 months (firm-fixed-price contract, profit capped at $10,000) Eligibility: U.S....
Full requirements and application instructions: official listing.
Similar Open Grants
DWSRF Lead Service Line Replacement (LSLR) Program
Environmental Protection Agency
National Estuary Program Watersheds Grants
Environmental Protection Agency
Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319
Environmental Protection Agency
2026 Diesel Emissions Reduction Act (DERA) National Program
Environmental Protection Agency
Clean Energy Program - Environmental Protection Agency
Environmental Protection Agency
EPA SBIR Phase II and Commercialization Option
Environmental Protection Agency
Balanced Prosecution of Transnational Organized Crime Cases
Bureau of International Narcotics-Law Enforcement
Capacity Building Grants for Non-Land-Grant Colleges of Agriculture Program
National Institute of Food and Agriculture
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
National Institutes of Health